Claims for Patent: 6,506,217

Summary for Patent: 6,506,217

Title:	Moldable post-implantation bone filler and method
Abstract:	Methods for correcting defects at bone repair sites are provided, which use a moldable, post-implantable bone conforming material. The method includes the steps of preparing a bone conforming material, shaping the moldable paste, curing the paste to form a hardened implant, disposing the implant at a repair site, allowing tissue to overlay the repair site during healing and if necessary, further molding the implant to the desired contours of the bony structure being repaired for up to eight weeks after the surgery by applying pressure to the tissue overlaying the implant.
Inventor(s):	Arnett; G. William (Santa Barbara, CA)
Assignee:	Arnett Facial Reconstruction Courses, Inc. (Santa Barbara, CA)
Application Number:	09/537,281
Patent Claims:	1. A moldable bone conforming material which remains moldable after being implanted for a period of time, comprising: at least one apatitic material; at least one fibrous material comprising microfibrillar collagen; and at least one fluid; wherein the at least one apatitic material, the at least one fibrous material and the at least one fluid when mixed together form a moldable paste which is shaped and cured outside of subject's body into an implant of a desired size and shape and which is then implanted at a bone repair site, wherein the implant is reshapeable at a post-operative bone repair site to achieve an aesthetic shape in a subject. 2. The moldable bone conforming material according to claim 1, wherein the apatitic material is in the form of a porous solid or granular particles. 3. The moldable bone conforming material according to claim 1, wherein the apatitic material is selected from the group consisting of hydroxyapatite, apatitic cements, cortical bone from human or animal cadavers, coral, acidic calcium phosphates, neutral calcium phosphates, fluoroapatite, carbonate apatite, chloroapatite, physiological bone serum and mixtures thereof. 4. The moldable bone conforming material according to claim 1, wherein the apatitic material is hydroxyapatite granules ranging in diameter from 425 to 1000 microns. 5. The moldable bone conforming material according to claim 1, wherein the fluid is a physiological buffer solution of sodium chloride. 6. The moldable bone conforming material according to claim 1, wherein the fluid contains antimicrobial agents. 7. The moldable bone conforming material according to claim 1, wherein the fluid contains a mixture of Polymixin B sulfate and Bacitracin. 8. The moldable bone conforming material according to claim 1, wherein the fluid is selected from the group consisting of a solution of sodium chloride, sodium citrate, Polymixin B sulfate, Bacitracin, sterile water, blood serum and mixtures thereof. 9. The moldable bone conforming material according to claim 1, wherein the apatitic material is hydroxyapatite granules ranging in diameter from 425 to 1000 microns and the physiological fluid is a mixture of sodium chloride solution, Polymixin B sulfate and Bacitracin. 10. A moldable bone conforming material which remains moldable after being implanted for a period of time, comprising: at least one apatitic material; at least one fibrous material comprising microfibrillar collagen; and at least one fluid; wherein the at least one apatitic material, the at least one fibrous material and the at least one fluid when mixed together form a moldable paste, which moldable paste when formed into an implant configuration is then cured to a hardened state to form a cured implant, which cured implant is suitable for implantation at a bone repair site, and which is reshapeable at a post-operative bone repair site to achieve an aesthetic shape in a subject. 11. The moldable bone conforming material according to claim 10, wherein the apatitic material is selected from the group consisting of hydroxyapatite, apatitic cements, cortical bone from human or animal cadavers, coral, acidic calcium phosphates, neutral calcium phosphates, fluoroapatite, carbonate apatite, chloroapatite, physiological bone serum and mixtures thereof. 12. The moldable bone conforming material according to claim 10, wherein the apatitic material is hydroxyapatite granules ranging in diameter from 425 to 1000 microns. 13. The moldable bone conforming material according to claim 10, wherein the fluid is a physiological buffer solution of sodium chloride. 14. The moldable bone conforming material according to claim 10, further including antimicrobial agents. 15. The moldable bone conforming material according to claim 10, wherein curing is affected by at least one of placing the shaped implant under a heat lamp, in a heated oven, in a dehydration unit, and in a dessicant. 16. A moldable bone conforming material which remains moldable after being implanted for a period of time, comprising: at least one apatitic material comprising hydroxyapatite granules ranging in diameter from 425 to 1000 microns; at least one fibrous material; and at least one fluid containing a mixture of Polymixin B sulfate and Bacitracin; wherein the at least one apatitic material, the at least one fibrous material and the at least one fluid are mixed together to form a moldable paste suitable for implantation at a bone repair site, wherein the moldable paste is capable of being shaped and cured outside of a subject's body into an implant of a desired size and shape, wherein the cured implant is remoldable at a post-operative bone repair site to achieve an aesthetic shape in a subject. 17. The moldable bone conforming material according to claim 16, wherein the fibrous material is in the form of collagen. 18. The moldable bone conforming material according to claim 16, wherein the fibrous material is selected from the group consisting of microfibrillar collagen, collagen fibrils, fibrin, gelatin, polysaccharide elastomers, natural rubber, fibrolamellar bone, cartilage and mixtures thereof. 19. The moldable bone conforming material according to claim 16, wherein the fluid further comprises a physiological buffer solution of sodium chloride. 20. The moldable bone conforming material according to claim 16, wherein the cured moldable paste, once implanted, can be shaped or reshaped, if necessary, at the post-operative bone repair site to achieve an aesthetic shape in a subject. 21. A method for correcting bone deficiencies at a bone repair site, comprising: preparing a bone conforming material which consists essentially of at least one apatitic material, at least one fibrous material, and a fluid, which when mixed together form a moldable paste; shaping the paste to form a desired implant configuration; curing the implant configuration to sufficiently harden the implant configuration; disposing the implant configuration at the bone repair site wherein it will absorb bodily fluid and become softened; molding the implant configuration further if necessary to conform the implant configuration to the bone repair site; closing the bone repair site, and remolding the implant configuration, after the bone repair site is closed, by applying pressure to the tissue overlaying the implant configuration to thereby affect reshaping of the implant configuration. 22. The method according to claim 21, wherein the step of remolding of the implant configuration can be carried out after any swelling and inflammation in the vicinity of the bone repair site has diminished. 23. The method according to claim 21, wherein the step of remolding the implant configuration can be carried out for approximately eight weeks. 24. The method according to claim 21, wherein bodily tissue will grow into the implant configuration during healing and eventually replace the implant configuration with tissue. 25. The method according to claim 21, wherein the apatitic material is in the form of a porous solid or granular particles. 26. The method according to claim 25, wherein the granular particles are microspherical particles. 27. The method according to claim 21, wherein the apatitic material is selected from the group consisting of at least one of hydroxyapatite, apatitic cements, cortical bone from human or animal cadavers, coral, acidic calcium phosphates, neutral calcium phosphates, fluoroapatite, carbonate apatite, chloroapatite, physiological bone serum and mixtures thereof. 28. The method according to claim 21, wherein the apatitic material is hydroxyapatite granules ranging in diameter from 425 to 1000 microns. 29. The method according to claim 21, wherein the fibrous material is in the form of collagen. 30. The method according to claim 21, wherein the fibrous material is selected from by the group consisting of at least one of microfibrillar collagen, collagen fibrils, fibrin, gelatin, polysaccharide elastomers, natural rubber, fibrolamellar bone, cartilage and mixtures thereof. 31. The method according to claim 21, wherein the fibrous material is microfibrillar collagen. 32. The method according to claim 21, wherein the fluid is a physiological buffer solution of sodium chloride. 33. The method according to claim 21, wherein the fluid contains antimicrobial agents. 34. The method according to claim 33, wherein the antimicrobial agents comprise a mixture of Polymixin B sulfate and Bacitracin. 35. The method according to claim 21, wherein the fluid is selected from the group consisting of a solution of at least one of sodium chloride, sodium citrate, Polymixin B sulfate, Bacitracin, in water, blood serum and mixtures thereof. 36. The method according to claim 21, wherein the curing step comprises at least one of placing the shaped implant under a heat lamp, in a heated oven, in a dehydration unit, under warm/hot air flow, and in a dessicant. 37. The method according to claim 21, wherein the curing step comprises placing the shaped implant under a heat lamp until the implant hardens. 38. The method according to claim 21, for use in maxillo-facial surgery and facial reconstruction surgery. 39. A method of surgery which permits post-operative reshaping of an implant at a bone repair site, comprising: exposing a site for bone repair; preparing a bone conforming material which consists essentially of at least one apatitic material, at least one fibrous material, and a fluid, which when mixed together form a moldable paste; shaping the paste to form a desired implant configuration; curing the implant configuration to sufficiently harden the implant configuration; disposing the implant configuration at the bone repair site; molding the implant configuration, if necessary, to conform to correct a bone defect or restore a shape to a bone at the bone repair site; closing the bone repair site; and remolding the implant after the surgery, if necessary, by applying pressure to the overlaying tissue to modify the shape of the implant configuration, wherein the step of remolding the implant configuration after the surgery can be accomplished without the need for anesthetics and can be carried out for approximately eight weeks after the surgery. 40. The surgical method according to claim 39, wherein the curing step comprises at least one of placing the implant configuration under a heat lamp, in a heated oven, in a dehydration unit, under warm/hot air flow, and in a dessicant. 41. The surgical method according to claim 39, wherein the curing step comprises placing the implant configuration under a heat lamp until the implant hardens. 42. The method of surgery according to claim 39, wherein the bone repair site and body member upon which the surgery is performed is the face. 43. The method of surgery according to claim 39, wherein the bone repair site and body member upon which the surgery performed is the cheekbone. 44. A method for correcting defects in a bony structure comprising: preparing a bone conforming material which consists essentially of at least one apatitic material, at least one fibrous material, and a fluid, which when mixed together form a moldable paste; shaping the paste to form an implant having a desired shape; curing the implant to sufficiently harden the implant; placing the implant at a bone repair site; molding the implant, if necessary, to correct the bone defect at the bone repair site; closing the bone repair site; allowing tissue to grow into and overlay the bone repair site during healing; and remolding the implant, if necessary, by applying direct pressure to the overlaying tissue to modify the shape of the implant, wherein the step of remolding the implant can be accomplished without the need for anesthetics and can be carried out for approximately eight weeks after application to the bone repair site.

Details for Patent 6,506,217

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	ZOSTAVAX	zoster vaccine live	For Injection	125123	05/25/2006		2019-03-29